{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:47:16Z","timestamp":1791341236368,"version":"4.3.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T00:00:00Z","timestamp":1407974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T00:00:00Z","timestamp":1407974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1038\/leu.2014.241","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T06:59:37Z","timestamp":1407999577000},"page":"556-566","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Augmented efficacy with the combination of blockade of the Notch-1 pathway, bortezomib and romidepsin in a murine MT-1 adult T-cell leukemia model"],"prefix":"10.1038","volume":"29","author":[{"given":"P","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M N","family":"Petrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K C","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R N","family":"Bamford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T A","family":"Waldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,14]]},"reference":[{"key":"BFleu2014241_CR1","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","volume":"78","author":"Y Hinuma","year":"1981","unstructured":"Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78: 6476\u20136480.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014241_CR2","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC . Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415\u20137419.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014241_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","volume":"113","author":"Y Yamada","year":"2001","unstructured":"Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 2001; 113: 375\u2013382.","journal-title":"Br J Haematol"},{"key":"BFleu2014241_CR4","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/sj.emboj.7600996","volume":"25","author":"A Vacca","year":"2006","unstructured":"Vacca A, Felli MP, Palermo R, Di Mario G, Calce A, Di Giovine M et al. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia. EMBO J 2006; 25: 1000\u20131008.","journal-title":"EMBO J"},{"key":"BFleu2014241_CR5","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2006.01.035","volume":"124","author":"JJ Wilson","year":"2006","unstructured":"Wilson JJ, Kovall RA . Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA. Cell 2006; 124: 985\u2013996.","journal-title":"Cell"},{"key":"BFleu2014241_CR6","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/sj.embor.7400585","volume":"6","author":"F Radtke","year":"2005","unstructured":"Radtke F, Schweisguth F, Pear W . The Notch \u2018gospel\u2019. EMBO Rep 2005; 6: 1120\u20131125.","journal-title":"EMBO Rep"},{"key":"BFleu2014241_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris JP 4th, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269\u2013271.","journal-title":"Science"},{"key":"BFleu2014241_CR8","doi-asserted-by":"publisher","first-page":"16619","DOI":"10.1073\/pnas.1010722107","volume":"107","author":"J Pancewicz","year":"2010","unstructured":"Pancewicz J, Taylor JM, Datta A, Baydoun HH, Waldmann TA, Hermine O et al. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia. Proc Natl Acad Sci USA 2010; 107: 16619\u201316624.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014241_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri1703","volume":"5","author":"M Karin","year":"2005","unstructured":"Karin M, Greten FR . NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5: 749\u2013759.","journal-title":"Nat Rev Immunol"},{"key":"BFleu2014241_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature04870","volume":"441","author":"M Karin","year":"2006","unstructured":"Karin M . Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441: 431\u2013436.","journal-title":"Nature"},{"key":"BFleu2014241_CR11","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.V98.4.1200","volume":"98","author":"T Portis","year":"2001","unstructured":"Portis T, Harding JC, Ratner L . The contribution of NF-kappaB activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors. Blood 2001; 98: 1200\u20131208.","journal-title":"Blood"},{"key":"BFleu2014241_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1385\/IR:34:1:1","volume":"34","author":"J Peloponese","year":"2006","unstructured":"Peloponese J, Yeung M, Jeang K-T . Modulation of nuclear factor-kB by human T-cell leukemia virus type 1 tax protein: Implications for oncogenesis and inflammation. Immunol Res 2006; 34: 1\u201312.","journal-title":"Immunol Res"},{"key":"BFleu2014241_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/08830180701703364","volume":"26","author":"R Horie","year":"2007","unstructured":"Horie R . NF-kappaB in pathogenesis and treatment of adult T-cell leukemia\/lymphoma. Int Rev Immunol 2007; 26: 269\u2013281.","journal-title":"Int Rev Immunol"},{"key":"BFleu2014241_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/35106079","volume":"1","author":"PA Marks","year":"2001","unstructured":"Marks PA, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK . Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer 2001; 1: 194\u2013202.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2014241_CR15","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1182\/blood-2010-10-312603","volume":"117","author":"RL Piekarz","year":"2011","unstructured":"Piekarz RL, Frye R, Prince HM, Kirschbaum MH, Zain J, Allen SL et al. Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. Blood 2011; 117: 5827\u20135834.","journal-title":"Blood"},{"issue":"15","key":"BFleu2014241_CR16","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/jnci\/92.15.1210","volume":"92","author":"PA Marks","year":"2000","unstructured":"Marks PA, Richon VM, Rifkind RA . Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 2000; 92 (15): 1210\u20131216.","journal-title":"J Natl Cancer Inst"},{"key":"BFleu2014241_CR17","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1128\/JVI.78.9.4582-4590.2004","volume":"78","author":"N Mori","year":"2004","unstructured":"Mori N, Matsuda T, Tadano M, Kinjo T, Yamada Y, Tsukasaki K et al. Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell line and primary adult T-cell leukemia cells. J Virol 2004; 78: 4582\u20134590.","journal-title":"J Virol"},{"key":"BFleu2014241_CR18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M . Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. Br J Haematol 1991; 79: 428\u2013437.","journal-title":"Br J Haematol"},{"key":"BFleu2014241_CR19","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1084\/jem.20070872","volume":"204","author":"BJ Thompson","year":"2007","unstructured":"Thompson BJ, Buonamici S, Sulis ML, Palomero T, Vilimas T, Basso G et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med 2007; 204: 1825\u20131835.","journal-title":"J Exp Med"},{"key":"BFleu2014241_CR20","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1084\/jem.20070876","volume":"204","author":"J O'Neil","year":"2007","unstructured":"O'Neil J, Grim J, Strack P, Rao S, Tibbitts D, Winter C et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 2007; 204: 1813\u20131824.","journal-title":"J Exp Med"},{"key":"BFleu2014241_CR21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/leu.2013.183","volume":"28","author":"V Agnusdei","year":"2014","unstructured":"Agnusdei V, Minuzzo S, Frasson C, Grassi A, Axelrod F, Satyal S et al. Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts. Leukemia 2014; 28: 278\u2013288.","journal-title":"Leukemia"},{"key":"BFleu2014241_CR22","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1038\/leu.2010.204","volume":"24","author":"L Zuurbier","year":"2010","unstructured":"Zuurbier L, Homminga I, Calvert V, te Winkel ML, Buijs-Gladdines JG, Kooi C et al. NOTCH1 and\/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols. Leukemia 2010; 24: 2014\u20132022.","journal-title":"Leukemia"},{"key":"BFleu2014241_CR23","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nm1636","volume":"13","author":"T Palomero","year":"2007","unstructured":"Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007; 13: 1203\u20131210.","journal-title":"Nat Med"},{"key":"BFleu2014241_CR24","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/leu.2011.265","volume":"26","author":"R Schwarzer","year":"2012","unstructured":"Schwarzer R, D\u00f6rken B, Jundt F . Notch is an essential upstream regulator of NF-\u03baB and is relevant for survival of Hodgkin and Reed\u2013Sternberg cells. Leukemia 2012; 26: 806\u2013813.","journal-title":"Leukemia"},{"key":"BFleu2014241_CR25","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1182\/blood-2009-07-235143","volume":"115","author":"T Sanda","year":"2010","unstructured":"Sanda T, Li X, Gutierrez A, Ahn Y, Neuberg DS, O'Neil J et al. Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia. Blood 2010; 115: 1735\u20131745.","journal-title":"Blood"},{"key":"BFleu2014241_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrc1880","volume":"6:0","author":"C Grabher","year":"2006","unstructured":"Grabher C, von Boehmer H, Look AT . Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 2006; 6:0 347\u2013359.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2014241_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/labinvest.3700700","volume":"88","author":"C Osipo","year":"2008","unstructured":"Osipo C, Golde TE, Osborne BA, Miele LA . Off the beaten pathway: the complex cross talk between Notch and NF-kappaB. Lab Invest 2008; 88: 11\u201317.","journal-title":"Lab Invest"},{"key":"BFleu2014241_CR28","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1128\/MCB.18.4.2077","volume":"18","author":"F Oswald","year":"1998","unstructured":"Oswald F, Liptay S, Adler G, Schmid RM . NF-\u03baB2 is a putative target gene of activated NOTCH-1 via RBP-J\u03ba. Mol Cell Biol 1998; 18: 2077\u20132088.","journal-title":"Mol Cell Biol"},{"key":"BFleu2014241_CR29","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1093\/emboj\/19.13.3337","volume":"19","author":"D Bellavia","year":"2000","unstructured":"Bellavia D, Campese AF, Alesse E, Vacca A, Felli MP, Balestri A et al. Constitutive activation of NF-kB and T-cell leukemia\/lymphoma in Notch3 transgenic mice. EMBO J 2000; 19: 3337\u20133348.","journal-title":"EMBO J"},{"key":"BFleu2014241_CR30","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1084\/jem.183.5.2025","volume":"183","author":"E Guan","year":"1996","unstructured":"Guan E, Wang J, Laborda J, Norcross M, Baeuerle PA, Hoffman T . T cell leukemia-associated human Notch\/translocation-associated Notch homologue has IkB-like activity and physically interacts with nuclear factor-kB proteins in T cells. J Exp Med 1996; 183: 2025\u20132032.","journal-title":"J Exp Med"},{"key":"BFleu2014241_CR31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1593\/neo.03388","volume":"6","author":"N Hironaka","year":"2004","unstructured":"Hironaka N, Mochida K, Mori N, Maeda M, Yamamoto N, Yamaoka S . Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells. Neoplasia 2004; 6: 266\u2013278.","journal-title":"Neoplasia"},{"key":"BFleu2014241_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/nm1524","volume":"13","author":"T Vilimas","year":"2007","unstructured":"Vilimas T, Mascarenhas J, Palomero T, Mandal M, Buonamici S, Meng F et al. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nat Med 2007; 13: 70\u201377.","journal-title":"Nat Med"},{"key":"BFleu2014241_CR33","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/sj.leu.2403400","volume":"18","author":"Y Satou","year":"2004","unstructured":"Satou Y, Nosaka K, Koya Y, Yasunaga JI, Toyokuni S, Matsuoka M . Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro. Leukemia 2004; 18: 1357\u20131363.","journal-title":"Leukemia"},{"key":"BFleu2014241_CR34","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s13402-011-0060-6","volume":"34","author":"F Chen","year":"2011","unstructured":"Chen F, Pisklakova A, Li M, Baz R, Sullivan DM, Nefedova Y . Gamma-secretase inhibitor enhances the cytotoxic effect of bortezomib in multiple myeloma. Cell Oncol (Dordr) 2011; 34: 545\u2013551.","journal-title":"Cell Oncol (Dordr)"},{"key":"BFleu2014241_CR35","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1182\/blood-2009-07-235663","volume":"116","author":"J Kikuchi","year":"2010","unstructured":"Kikuchi J, Wada T, Shimizu R, Izumi T, Akutsu M, Mitsunaga K et al. Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma. Blood 2010; 116: 406\u2013417.","journal-title":"Blood"},{"key":"BFleu2014241_CR36","doi-asserted-by":"publisher","first-page":"6274","DOI":"10.1182\/blood-2011-03-339879","volume":"118","author":"SJ Harrison","year":"2011","unstructured":"Harrison SJ, Quach H, Link E, Seymour JF, Ritchie DS, Ruell S et al. A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma. Blood 2011; 118: 6274\u20136283.","journal-title":"Blood"},{"key":"BFleu2014241_CR37","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1158\/1078-0432.CCR-09-1937","volume":"16","author":"L Paoluzzi","year":"2010","unstructured":"Paoluzzi L, Scotto L, Marchi E, Zain J, Seshan VE, O'Connor OA . Romidepsin and belinostat synergize the antineoplastic effect of bortezomib in Mantle cell lymphoma. Clin Cancer Res 2010; 16: 554\u2013565.","journal-title":"Clin Cancer Res"},{"key":"BFleu2014241_CR38","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1158\/1078-0432.CCR-07-1934","volume":"14","author":"Y Dai","year":"2008","unstructured":"Dai Y, Chen S, Kramer LB, Funk VL, Dent P, Grant S . Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells. Clin Cancer Res 2008; 14: 549\u2013558.","journal-title":"Clin Cancer Res"},{"key":"BFleu2014241_CR39","doi-asserted-by":"publisher","first-page":"34427","DOI":"10.1074\/jbc.M302659200","volume":"278","author":"MJ LaVoie","year":"2003","unstructured":"LaVoie MJ, Selkoe DJ . The notch ligands, Jagged and Delta, are sequentially processed by \u03b1-secretase and presenilin\/\u03b3-secretase and release signaling fragments. J Biol Chem 2003; 278: 34427\u201334437.","journal-title":"J Biol Chem"},{"key":"BFleu2014241_CR40","doi-asserted-by":"publisher","first-page":"13607","DOI":"10.1074\/jbc.C300016200","volume":"278","author":"CE Bland","year":"2003","unstructured":"Bland CE, Kimberly P, Rand MD . Notch-induced proteolysis and nuclear localization of the Delta ligand. J Biol Chem 2003; 278: 13607\u201313610.","journal-title":"J Biol Chem"},{"key":"BFleu2014241_CR41","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1242\/dev.127.7.1373","volume":"127","author":"AL Parks","year":"2000","unstructured":"Parks AL, Klueg KM, Stout JR, Muskavitch MA . Ligand endocytosis drives receptor dissociation and activation in the Notch pathway. Development 2000; 127: 1373\u20131385.","journal-title":"Development"},{"key":"BFleu2014241_CR42","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3892\/ol.2013.1523","volume":"6","author":"Y Yuan","year":"2013","unstructured":"Yuan Y, Lu X, Chen X, Shao HW, Huang SL Jagged 1 contributes to the drug resistance of Jurkat cells in contact with human umbilical cord-derived mesenchymal stem cells. Onco Lett 2013; 6: 1000\u20131016.","journal-title":"Onco Lett"},{"key":"BFleu2014241_CR43","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1182\/blood.V99.9.3398","volume":"99","author":"F Jundt","year":"2002","unstructured":"Jundt F, Anagnostopoulos I, F\u00f6rster R, Mathas S, Stein H, D\u00f6rken B . Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood 2002; 99: 3398\u20134303.","journal-title":"Blood"},{"key":"BFleu2014241_CR44","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1158\/0008-5472.CAN-04-1890","volume":"65","author":"BW Purow","year":"2005","unstructured":"Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J et al. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 2005; 65: 2353\u20132363.","journal-title":"Cancer Res"},{"key":"BFleu2014241_CR45","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1182\/blood-2010-12-326694","volume":"118","author":"AH Nwabo Kamdje","year":"2011","unstructured":"Nwabo Kamdje AH, Mosna F, Bifari F, Lisi V, Bassi G, Malpeli G et al. Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells. Blood 2011; 118: 380\u2013389.","journal-title":"Blood"},{"key":"BFleu2014241_CR46","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1172\/JCI35090","volume":"118","author":"MY Chiang","year":"2008","unstructured":"Chiang MY, Xu L, Shestova O, Histen G, L'heureux S, Romany C et al. Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia. J Clin Invest 2008; 118: 3181\u20133194.","journal-title":"J Clin Invest"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2014241.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2014241","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2014241.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:37:37Z","timestamp":1648744657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2014241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,14]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["BFleu2014241"],"URL":"https:\/\/doi.org\/10.1038\/leu.2014.241","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,14]]},"assertion":[{"value":"9 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}